Jeppe Øvlesen — CEO
Roles
02.09.2026 – 02.09.2026
Transactions (including via associated entities)
| Date | Issuer | Nature | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 02.09.2026 | SynAct Pharma AB Stockholm | SoldDisposal via Quantass ApS | 150,000 | SEK 17.80 | SEK 2,670,000.00 | ↗ |
| Date | Issuer | Nature | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 02.09.2026 | SynAct Pharma AB Stockholm | SoldDisposal via Quantass ApS | 150,000 | SEK 17.80 | SEK 2,670,000.00 | ↗ |